Stephen G. Oswald
Okay. Thank you, Suman. Thanks, everyone, for joining us today for our second quarter conference call. Today, and as usual, I'll give an update of the current situation at the company. After which, Suman will review our financials in detail. Let me start off again on this quarterly call with Ducommun's VISION 2027 game plan for investors as we continue our third year of execution in 2025. The strategy and vision were developed coming out of the COVID pandemic over the summer and fall of 2022, unanimously approved by the common Board in November 2022, and then presented the following month in New York to investors where we got excellent feedback. Since that time, Ducommun's management has been executing the strategy by increasing the revenue percentage of engineered product and aftermarket content, which is at 23% this year, up from 15% in 2022, consolidating our rooftop footprint in contract manufacturing, continuing our focused acquisition program, executing the offloading strategy with defense primes and high-growth segments, driving value-added pricing, expanding content on our key commercial aerospace platforms. All of us here as well as my fellow Board members continue to have a high level of conviction in the VISION 2027 strategy and financial goals and believe the market catalysts ahead present a unique value creation opportunity for shareholders. The Q2 2025 results show again the strategy initiatives are working, with both gross and adjusted EBITDA margins, for example, at record levels with more opportunities to come for DCO. For Q2, I'm happy to report revenues reached a new quarterly record of $202.3 million or 2.7% over prior year, beating our prior record of $201.4 million in Q3 of last year and also making this our 17th consecutive quarter with year-over-year growth in revenue. We achieved this despite headwinds in commercial aerospace build rates, destocking at BA and SPR, which was anticipated, and the continued strategic pruning of our noncore industrial businesses, the right thing to do. The revenue performance was driven by continued strength in our defense business, which grew 16% during the quarter and was our second consecutive quarter with double-digit growth. The growth in defense was driven by a very strong performance in our missile franchise, which grew by 39% during the quarter, along with DCO's radar business, much newer to DCO, up 46%. Now the outlook for our defense business continues to look great. In addition to the highlights I just mentioned, the Apache blades, Tomahawk cables, and the TOW missile case are scheduled to be back starting in the second half and into 2026 as we are nearing final approvals from RTX and BA. In addition, and previously discussed, our team continues to build scale at other defense customers outside of RTX, which is and has been a long-term goal. Northrop Grumman is a great example of this strategic effort. I also thought it was the right time with the recent Wall Street Journal article on Missiles published on July 23 to highlight DCO's missile franchise and how well it's positioned to benefit from the replenishment of depleted worldwide inventories mentioned in the article, along with, in general, very robust U.S. and FMS order activity. For background, Ducommun is a supplier on over a dozen key missile platforms, including AMRAAM, MIR, PAC-3, SM2, SM3, SM6, Tomahawk and TOW amongst others. Our missile business is up 39% in the second quarter, and our missile backlog also increased 30% compared to the year ago. Excellent news. For greater context, DCO currently supports 18 missile programs with at least $750,000 of revenue in the last 12 months. Complementing our missile portfolios, our strong radar franchise, which is up and coming, covering marquee programs such as the SPY-6 radar, the LTAMDS radar, which is part of the Patriot missile defense system. The TPY-2 radar used on the THAAD missile defense system, and the G/ATOR radar used by the U.S. Marine Corps and various other radar platforms. This combination of both missile and radar platforms positioned us well in the current environment and also aligns us with key defense priorities outlined in the U.S. defense budget, including the Golden Dome as well as NATO priorities. We are in active negotiations with the defense right now for record levels of the SM3 as an example, and view our missile and radar franchises a bedrock for growth now and the next few years ahead. The strong growth in our defense business more than offset lower revenue in our commercial aerospace business, which declined 10% in the quarter. However, the outlook is promising for commercial aerospace as Boeing continues to perform at improved build rates and they get through the destocking along with SPR. I also want to add that everything we see out of Boeing Commercial in the last 3 or 4 months has been very encouraging, both on the 737 and 787, our main platforms. We're optimistic that bill rates will be growing from 38 to 42 on the 737 MAX soon as outlined by Boeing on recent calls. Gross margin also grew $2.5 million to 26.6% in Q2, matching the record gross margin percentage achieved in Q1, up 60 basis points year-over-year from 26% as we continue to realize benefits from our growing engineered product portfolio with aftermarket, strategic value pricing initiatives, restructuring actions and productivity improvements. We have ceased manufacturing operations in both our Monrovia, California and Berryville, Arkansas operations. We expect to see those savings be higher as the receiving plants ramp up later this year and more fully in 2026. For adjusted operating income margins in Q2, the team delivered 9.9%, which is just below the prior year of 10.1%. Electronic Systems segment margin grew nicely in the quarter, with a good mix of profitable business and improvements in productivity. Adjusted EBITDA hit another record in Q2, achieving 16% of revenue for the first time, up $2.4 million to $32.4 million. Fantastic. This is our third quarter with adjusted EBITDA above $30 million and represents an expansion of 80 basis points above prior year and continues the strong momentum we saw in 2024 as we work towards the 18% goal in our VISION 2027 plan, 2.5 years to go. GAAP diluted EPS was $0.82 a share in Q2 2025 versus $0.52 a share for Q2 2024. And with adjustments, diluted EPS was a strong $0.88 a share compared to adjusted diluted EPS of $0.83 in the prior year quarter. The higher GAAP and adjusted diluted EPS during the quarter was driven by improved operating income as well as lower interest costs due to lower interest rates along with a lower outstanding debt balance. The company's consolidated backlog continues to be strong at $1.02 billion, but did decrease $50 million year-over-year due to timing of awards. We are in active negotiations with the customers on a number of meaningful opportunities, and based on our current pipeline, we expect a significant uptick in orders in the second half. The defense backlog was flat compared to the prior year quarter and is at $593 million, but expected to ramp up in the back half of the year. The commercial aerospace backlog decreased by $47 million compared to the prior year quarter due to lower OEM production rates and destocking, which we fully expect to come back. In December 2022, we set a target of generating 25% of our revenues from engineered products which was 9% in 2017 and 15% in 2022. In 2024, we reported that our engineered product business drove 23% of our total revenue, up from 19% in 2023, positioning us well ahead of the curve in achieving our VISION 2027 goal, and we're certainly pushing for a lot more. We achieved this both through focused investment, driving organic growth in those current business as well as the BLR acquisition. In Q2 2025, we have maintained this 23% mix and continue to work on both organic and inorganic opportunities to drive this higher. We have made tremendous progress to date and I'm proud of our team and strategic plan. As for the second half of 2025, we are positioned to benefit from the expected Boeing recovery in the second half, along with continued momentum in defense. For revenue guidance, after somewhat flattish first half, we're expecting mid-single-digit growth in Q3 with low double-digit growth in Q4. In addition, we believe tariffs will have limited and no material impact on our 2025 revenues, a good story for our investors. Also, I want to reiterate as well that Ducommun is a U.S. manufacturer with U.S. employees, and 95% of our revenue is produced in the U.S. Our only other facility is based in Guaymas, Mexico, and that production is less than 5% of our revenue, and thankfully covered under the USMCA, exempting us from tariffs. The other good news is Ducommun's revenue into China is almost entirely one program for an Airbus supplier, who is owned by the government, constitute less than 2% of our revenue, and we have not seen any impact at this point on tariffs for our revenue. On the supplier side, we do procure some parts from Europe and Asia, but it is manageable. And so far, the impact has been seen to be pretty de minimis. We will continue to monitor it as the situation evolves. But at this point, we certainly don't see it as being something as a material impact to the company. Now let me provide some color on our markets, products and programs. Beginning with our military and space sector, we saw revenues of $117 million compared to $101 million in Q2 2024. Growth was driven by significant activity in missile programs such as TOW and AMRAAM, as well as solid growth in military rotorcraft on the G/ATOR radar and on a classified program. We also ended the second quarter with a backlog of $593 million, flat to prior year, representing 58% of Ducommun's total backlog. Within our commercial aerospace operations, second quarter revenue declined 10% year-over-year to $78 million, driven mainly by lower rates on Boeing platforms, commercial helicopters and in-flight entertainment. As I mentioned earlier, we believe that finally, a much better story is ahead for BA and MAX now that production is ramping up again, and they're working through their overstocked inventory. The backlog within our commercial aerospace business was $404 million at the end of the second quarter, decreasing $47 million compared to prior year driven by lower rates on Boeing platforms. We expect this to recover as production rates ramp up in late 2025 and 2026. Revenue in our industrial business declined by 23% to $8 million during Q2 as we continually strategically prune our noncore business on the portfolio. This will benefit the company in the longer term as we transition that capacity to our core aerospace and defense platforms. With that, I'll let Suman to review our financial results in detail. Suman?